Your browser doesn't support javascript.
loading
Patient-reported outcomes in patients with cystic fibrosis with a G551D mutation on ivacaftor treatment: results from a cross-sectional study.
Bell, Scott C; Mainz, Jochen G; MacGregor, Gordon; Madge, Susan; Macey, Julie; Fridman, Moshe; Suthoff, Ellison D; Narayanan, Siva; Kinnman, Nils.
Affiliation
  • Bell SC; Department of Thoracic Medicine, The Prince Charles Hospital and QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. scott.bell@qimrberghofer.edu.au.
  • Mainz JG; Jena University Hospital, Jena, Germany.
  • MacGregor G; Brandenburg Medical School (MHB), University , Brandenburg an der Havel, Germany.
  • Madge S; Gartnavel General Hospital, Glasgow, UK.
  • Macey J; Royal Brompton Hospital, London, UK.
  • Fridman M; University Hospital Bordeaux, Bordeaux, France.
  • Suthoff ED; AMF Consulting, Los Angeles, CA, USA.
  • Narayanan S; Formerly of Vertex Pharmaceuticals Incorporated, Boston, MA, USA.
  • Kinnman N; Decision Resources Group, Burlington, MA, USA.
BMC Pulm Med ; 19(1): 146, 2019 Aug 13.
Article in En | MEDLINE | ID: mdl-31409396

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quinolones / Cystic Fibrosis Transmembrane Conductance Regulator / Cystic Fibrosis / Benzodioxoles / Aminophenols / Aminopyridines Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Child / Female / Humans / Male Language: En Journal: BMC Pulm Med Year: 2019 Type: Article Affiliation country: Australia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quinolones / Cystic Fibrosis Transmembrane Conductance Regulator / Cystic Fibrosis / Benzodioxoles / Aminophenols / Aminopyridines Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Child / Female / Humans / Male Language: En Journal: BMC Pulm Med Year: 2019 Type: Article Affiliation country: Australia